Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takechi

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Toxicological Sciences|July 3, 2020
The effect of dihydropyrazines on lipopolysaccharide-stimulated human hepatoma HepG2 cells via regulating the TLR4-MyD88-mediated NF-κB signaling pathwayMadoka Esaki, Takumi Ishida, Yuu Miyauchi, et al.
The Journal of Toxicological Sciences|October 1, 2025
Dihydropyrazine activates the CAMKK2-AMPK-ULK1 signaling pathway in human hepatoma HepG2 cellsMadoka Sawai, Yuu Miyauchi, Hisao Kansui, et al.
Biological & Pharmaceutical Bulletin|July 6, 2005
The Role of dihydropyrazines in accelerated death of Escherichia coli on addition of copper(II)Osamu Takeda, Shinji Takechi, Takahiko Katoh, et al.
Biological & Pharmaceutical Bulletin|February 3, 2009
Oxidative stress induced by a dihydropyrazine derivativeShinji Takechi, Kazuhide Nakahara, Masaru Adachi, et al.
The Journal of Toxicological Sciences|September 1, 2022
Dihydropyrazine suppresses TLR4-dependent inflammatory responses by blocking MAPK signaling in human hepatoma HepG2 cellsMadoka Sawai, Yuu Miyauchi, Takumi Ishida, et al.
The Journal of Toxicological Sciences|April 7, 2011
Glutathione depression by dihydropyrazine derivativeShinji Takechi, Shigeru Ito, Nobuhiro Kashige, et al.
Chemical & Pharmaceutical Bulletin|December 3, 2009
Tetraazaindenes derived from dihydropyrazines with DNA strand-breaking activityKazuhide Nakahara, Shinji Takechi, Koki Yamaguchi, et al.
The Journal of Toxicological Sciences|November 1, 2021
Molecular mechanism of dihydropyrazine-induced cytotoxicity: the possibility of an independent pathway from the receptor for advanced glycation end productsYuu Miyauchi, Madoka Sawai, Takumi Ishida, et al.
The Journal of Toxicological Sciences|July 14, 2015
Identification of dihydropyrazine-glutathione adductsShinji Takechi, Shigeru Ito, Nobuhiro Kashige, et al.
Journal of the Neurological Sciences|October 7, 2004
Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusionsTakekazu Ohi, Kazuki Nabeshima, Shinsuke Kato, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Toxicological Sciences|July 3, 2020
The effect of dihydropyrazines on lipopolysaccharide-stimulated human hepatoma HepG2 cells via regulating the TLR4-MyD88-mediated NF-κB signaling pathwayMadoka Esaki, Takumi Ishida, Yuu Miyauchi, et al.
The Journal of Toxicological Sciences|October 1, 2025
Dihydropyrazine activates the CAMKK2-AMPK-ULK1 signaling pathway in human hepatoma HepG2 cellsMadoka Sawai, Yuu Miyauchi, Hisao Kansui, et al.
Biological & Pharmaceutical Bulletin|July 6, 2005
The Role of dihydropyrazines in accelerated death of Escherichia coli on addition of copper(II)Osamu Takeda, Shinji Takechi, Takahiko Katoh, et al.
Biological & Pharmaceutical Bulletin|February 3, 2009
Oxidative stress induced by a dihydropyrazine derivativeShinji Takechi, Kazuhide Nakahara, Masaru Adachi, et al.
The Journal of Toxicological Sciences|September 1, 2022
Dihydropyrazine suppresses TLR4-dependent inflammatory responses by blocking MAPK signaling in human hepatoma HepG2 cellsMadoka Sawai, Yuu Miyauchi, Takumi Ishida, et al.
The Journal of Toxicological Sciences|April 7, 2011
Glutathione depression by dihydropyrazine derivativeShinji Takechi, Shigeru Ito, Nobuhiro Kashige, et al.
Chemical & Pharmaceutical Bulletin|December 3, 2009
Tetraazaindenes derived from dihydropyrazines with DNA strand-breaking activityKazuhide Nakahara, Shinji Takechi, Koki Yamaguchi, et al.
The Journal of Toxicological Sciences|November 1, 2021
Molecular mechanism of dihydropyrazine-induced cytotoxicity: the possibility of an independent pathway from the receptor for advanced glycation end productsYuu Miyauchi, Madoka Sawai, Takumi Ishida, et al.
The Journal of Toxicological Sciences|July 14, 2015
Identification of dihydropyrazine-glutathione adductsShinji Takechi, Shigeru Ito, Nobuhiro Kashige, et al.
Journal of the Neurological Sciences|October 7, 2004
Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusionsTakekazu Ohi, Kazuki Nabeshima, Shinsuke Kato, et al.
Pageof 4